Palau Pharma is a product-driven biopharmaceutical company focused on the discovery and development of innovative, improved and safer medicines for the treatment of diseases with identified unmet medical needs in the inflammatory and autoimmune fields. Founded in November 2006 through a spin-out from Grupo Uriach.
Looking for a particular Palau Pharma employee's phone or email?
The Palau Pharma annual revenue was $52.1 million in 2026.
5 people are employed at Palau Pharma.
Palau Pharma is based in Sant Andreu de la Barca, Catalonia.
The NAICS codes for Palau Pharma are [325, 3254, 326, 32].
The SIC codes for Palau Pharma are [283, 30, 308, 28].